• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立对多囊肾病患者具有意义的以患者为中心的结局:多囊肾病患者、护理人员及研究人员的研究重点

Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease: Patient, Caregiver, and Researcher Priorities for Research in Polycystic Kidney Disease.

作者信息

Mustafa Reem A, Kawtharany Hassan, Kalot Mohamad A, Lumpkins Crystal Y, Kimminau Kim S, Creed Cathy, Fowler Kevin, Perrone Ronald D, Jaure Allison, Cho Yeoungjee, Baron David, Yu Alan S L

机构信息

Division of Nephrology and Hypertension,Department of Internal Medicine, University of Kansas Medical Centre, Kansas City, Kansas.

Evidence-Based Practice and Impact Center, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas.

出版信息

Kidney360. 2025 Apr 1;6(4):573-582. doi: 10.34067/KID.0000000695. Epub 2025 Jan 14.

DOI:10.34067/KID.0000000695
PMID:39808496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12045497/
Abstract

KEY POINTS

Participants are less concerned about mortality than they are about kidney health. Psychological effect emerged as the most important theme regarding the effects of polycystic kidney disease on patients.

BACKGROUND

Patient involvement in research can help to ensure that the evidence generated aligns with their needs and priorities. In the Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease (PKD) project, we aimed to identify patient-important outcomes and discuss the effect of PKD on patients.

METHODS

Nine focus groups were held with adult patients with PKD, caregivers, and clinical or research experts in PKD. We used a nominal, multivote technique to rank patient-important outcomes to be prioritized by future PKD research. We conducted a thematic analysis of verbatim transcriptions to identify themes regarding the effect of PKD on their daily lives. Other focus group topics included insurability and patient engagement.

RESULTS

Ninety patients and/or caregivers and eight clinicians and/or researchers participated in the focus groups. Nine focus groups yielded 35 outcomes important to patients that were grouped into six categories, ranked in order of importance: kidney health, comorbidities, lifestyle, psychological effect, family and awareness, and mortality. Regarding the effect of PKD on the patient's daily lives, we identified five themes, listed in order of importance: psychological effect, effect on daily living, issues affecting decision making, health care-related issues, and PKD-specific testing dilemmas.

CONCLUSIONS

This study of stakeholder engagement in patients with PKD revealed important priorities and values that should be considered for future research and when caring for patients with PKD. Future research should focus on kidney health and managing comorbidities in patients with PKD. This will help to bridge the knowledge gap and develop meaningful comparative effectiveness research in PKD.

摘要

关键点

参与者对死亡率的关注低于对肾脏健康的关注。心理影响成为多囊肾病对患者影响方面最重要的主题。

背景

患者参与研究有助于确保所产生的证据符合他们的需求和优先事项。在“为多囊肾病(PKD)患者建立有意义的以患者为中心的结局”项目中,我们旨在确定对患者重要的结局,并讨论PKD对患者的影响。

方法

与成年PKD患者、护理人员以及PKD方面的临床或研究专家进行了9次焦点小组讨论。我们使用名义多投票技术对未来PKD研究应优先考虑的对患者重要的结局进行排序。我们对逐字记录进行了主题分析,以确定PKD对他们日常生活影响的主题。其他焦点小组主题包括可保险性和患者参与度。

结果

90名患者和/或护理人员以及8名临床医生和/或研究人员参加了焦点小组讨论。9次焦点小组讨论得出了35项对患者重要的结局,这些结局被分为六类,按重要性排序:肾脏健康、合并症、生活方式、心理影响、家庭与认知以及死亡率。关于PKD对患者日常生活的影响,我们确定了五个主题,按重要性排序:心理影响、对日常生活的影响、影响决策的问题、医疗保健相关问题以及PKD特异性检测困境。

结论

这项关于PKD患者利益相关者参与的研究揭示了未来研究以及照顾PKD患者时应考虑的重要优先事项和价值观。未来的研究应关注PKD患者的肾脏健康和合并症管理。这将有助于弥合知识差距,并开展有意义的PKD比较疗效研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/435fc7df0247/kidney360-6-573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/f5614713f0fe/kidney360-6-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/14c23be37f83/kidney360-6-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/f5b074da9f4b/kidney360-6-573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/435fc7df0247/kidney360-6-573-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/f5614713f0fe/kidney360-6-573-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/14c23be37f83/kidney360-6-573-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/f5b074da9f4b/kidney360-6-573-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/716d/12045497/435fc7df0247/kidney360-6-573-g004.jpg

相似文献

1
Establishing Meaningful Patient-Centered Outcomes with Relevance for Patients with Polycystic Kidney Disease: Patient, Caregiver, and Researcher Priorities for Research in Polycystic Kidney Disease.建立对多囊肾病患者具有意义的以患者为中心的结局:多囊肾病患者、护理人员及研究人员的研究重点
Kidney360. 2025 Apr 1;6(4):573-582. doi: 10.34067/KID.0000000695. Epub 2025 Jan 14.
2
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.建立常染色体显性遗传性多囊肾病的核心结局集:肾脏病预后质量倡议-多囊肾病(SONG-PKD)共识研讨会报告。
Am J Kidney Dis. 2021 Feb;77(2):255-263. doi: 10.1053/j.ajkd.2020.05.024. Epub 2020 Aug 6.
3
Identifying patient-important outcomes in polycystic kidney disease: An international nominal group technique study.确定多囊肾病患者重要的结局:一项国际名义群体技术研究。
Nephrology (Carlton). 2019 Dec;24(12):1214-1224. doi: 10.1111/nep.13566. Epub 2019 May 2.
4
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.肾脏病-多囊肾病标准化结局(SONG-PKD):建立多囊肾病核心结局集的研究方案
Trials. 2017 Nov 23;18(1):560. doi: 10.1186/s13063-017-2298-4.
5
Research priority setting in kidney disease: a systematic review.肾脏病研究重点制定:系统评价。
Am J Kidney Dis. 2015 May;65(5):674-83. doi: 10.1053/j.ajkd.2014.11.011. Epub 2015 Jan 10.
6
Systematic review on outcomes used in clinical research on autosomal recessive polycystic kidney disease-are patient-centered outcomes our blind spot?常染色体隐性遗传性多囊肾病临床研究结局指标的系统评价:以患者为中心的结局是否是我们的盲点?
Pediatr Nephrol. 2021 Dec;36(12):3841-3851. doi: 10.1007/s00467-021-05192-8. Epub 2021 Aug 12.
7
Relevance of ultrasound examination in general practice. A case report of a patient with autosomal dominant polycystic kidney disease.超声检查在全科医疗中的相关性。一例常染色体显性多囊肾病患者的病例报告。
J Ultrason. 2013 Sep;13(54):344-9. doi: 10.15557/JoU.2013.0035. Epub 2013 Sep 30.
8
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program.常染色体显性多囊肾病卓越中心项目的使命与未来计划。
Kidney360. 2025 Jan 1;6(1):159-166. doi: 10.34067/KID.0000000652. Epub 2024 Nov 19.
9
Range and Variability of Outcomes Reported in Randomized Trials Conducted in Patients With Polycystic Kidney Disease: A Systematic Review.多囊肾病患者随机试验报告的结局范围和变异性:系统评价。
Am J Kidney Dis. 2020 Aug;76(2):213-223. doi: 10.1053/j.ajkd.2019.12.003. Epub 2020 Mar 11.
10
Research priorities for autosomal dominant polycystic kidney disease: a UK priority setting partnership.常染色体显性遗传性多囊肾病研究重点:英国优先事项设定伙伴关系。
BMJ Open. 2022 Jun 15;12(6):e055780. doi: 10.1136/bmjopen-2021-055780.

本文引用的文献

1
Healthcare Resource Utilization and Costs Associated with Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病相关的医疗资源利用与成本
J Health Econ Outcomes Res. 2014 Jul 29;2(1):63-74. doi: 10.36469/9889. eCollection 2014.
2
Complex PKD1 Genetics in Early-Onset Cystic Kidney Disease.早发性囊性肾病中复杂的PKD1基因学
Kidney360. 2023 Mar 1;4(3):297-298. doi: 10.34067/KID.0000000000000110.
3
Comparison of outcomes of chronic kidney disease based on etiology: a prospective cohort study from KNOW-CKD.基于病因的慢性肾脏病结局比较:一项来自 KNOW-CKD 的前瞻性队列研究。
Sci Rep. 2023 Mar 2;13(1):3570. doi: 10.1038/s41598-023-29844-x.
4
Health Disparities in Kidney Failure Among Patients With Autosomal Dominant Polycystic Kidney Disease: A Cross-Sectional Study.常染色体显性多囊肾病患者肾衰竭中的健康差异:一项横断面研究。
Kidney Med. 2022 Dec 5;5(2):100577. doi: 10.1016/j.xkme.2022.100577. eCollection 2023 Feb.
5
Caregiver Burden of Autosomal Dominant Polycystic Kidney Disease: A Qualitative Study.常染色体显性多囊肾病患者照料者的负担:一项定性研究。
Kidney Med. 2022 Dec 14;5(2):100587. doi: 10.1016/j.xkme.2022.100587. eCollection 2023 Feb.
6
A Systematic Review of Reported Outcomes in ADPKD Studies.常染色体显性多囊肾病(ADPKD)研究中报告结果的系统评价
Kidney Int Rep. 2022 Jul 5;7(9):1964-1979. doi: 10.1016/j.ekir.2022.06.012. eCollection 2022 Sep.
7
Autosomal Dominant Polycystic Kidney Disease Prevalence among a Racially Diverse United States Population, 2002 through 2018.2002 年至 2018 年,美国不同种族人群中常染色体显性遗传性多囊肾病的患病率。
Kidney360. 2021 Sep 22;2(12):2010-2015. doi: 10.34067/KID.0004522021. eCollection 2021 Dec 30.
8
Excess healthcare costs in patients with autosomal dominant polycystic kidney disease by renal dysfunction stage.肾功能障碍阶段常染色体显性多囊肾病患者的过度医疗费用。
J Med Econ. 2021 Jan-Dec;24(1):193-201. doi: 10.1080/13696998.2021.1877146.
9
Establishing a Core Outcome Set for Autosomal Dominant Polycystic Kidney Disease: Report of the Standardized Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD) Consensus Workshop.建立常染色体显性遗传性多囊肾病的核心结局集:肾脏病预后质量倡议-多囊肾病(SONG-PKD)共识研讨会报告。
Am J Kidney Dis. 2021 Feb;77(2):255-263. doi: 10.1053/j.ajkd.2020.05.024. Epub 2020 Aug 6.
10
The societal economic burden of autosomal dominant polycystic kidney disease in the United States.美国常染色体显性多囊肾病的社会经济负担。
BMC Health Serv Res. 2020 Feb 18;20(1):126. doi: 10.1186/s12913-020-4974-4.